Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INTERIM intermittent imatinib study in elderly patients with chronic myeloid leukemia in stable complete cytogenetic response
2007-005102-42Phase 2Active
- Sponsor
- ASST Spedali Civili di Brescia
- Start
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of imatinib in chronic myelogenous leukemia (CML), sponsored by ASST Spedali Civili di Brescia. Started Dec 2007; status: active.
02
Drugs
03
Conditions
chronic myelogenous leukemia (CML)
Beyond the preview
Go deeper on 2007-005102-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005102-42.